C5836476
influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension
Concept
Cross-maps
Source vocabularies
Atoms not loaded for this concept.
Related concepts
Common questions
What is the UMLS CUI for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension?
influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension is coded as C5836476 in UMLS.
What is UMLS code C5836476?
C5836476 is the UMLS identifier for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension. It is included in the current NLM UMLS Metathesaurus release.
What is the RxNorm mapping for C5836476?
C5836476 maps to RxNorm 2647702.